Stay updated on Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.

Latest updates to the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov record for a completed Phase 3 ensifentrine study in people with COPD is displayed, with study design, outcomes, participation criteria, locations, and related publications and documents.SummaryDifference100%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page remains a 403 error.SummaryDifference0.2%

- Check16 days agoChange DetectedA banner announces NIH’s transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedNo additions or deletions are present in the provided data for this page.SummaryDifference0.2%

Stay in the know with updates to Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.